These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 35777870)

  • 1. Xpert Ultra stool testing to diagnose tuberculosis in children in Ethiopia and Indonesia: a model-based cost-effectiveness analysis.
    Mafirakureva N; Klinkenberg E; Spruijt I; Levy J; Shaweno D; de Haas P; Kaswandani N; Bedru A; Triasih R; Gebremichael M; Dodd PJ; Tiemersma EW
    BMJ Open; 2022 Jul; 12(7):e058388. PubMed ID: 35777870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modeling the patient and health system impacts of alternative xpert® MTB/RIF algorithms for the diagnosis of pulmonary tuberculosis in Addis Ababa, Ethiopia.
    Tesfaye A; Fiseha D; Assefa D; Klinkenberg E; Balanco S; Langley I
    BMC Infect Dis; 2017 May; 17(1):318. PubMed ID: 28464797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Simple One-Step (SOS) Stool Processing Method for Use with the Xpert MTB/RIF Assay for a Child-Friendly Diagnosis of Tuberculosis Closer to the Point of Care.
    de Haas P; Yenew B; Mengesha E; Slyzkyi A; Gashu Z; Lounnas M; Tesfaye E; Bedru A; Tiemersma E; Kremer K; Amare M; Diriba G; Zerihun B; Gudina T; Tegegn B; Bonnet M; Negeri C; Klinkenberg E
    J Clin Microbiol; 2021 Jul; 59(8):e0040621. PubMed ID: 34076469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimization of the Simple One-Step Stool Processing Method to Diagnose Tuberculosis: Evaluation of Robustness and Stool Transport Conditions for Global Implementation.
    Yenew B; de Haas P; Diriba G; Kebede A; Sherefdin B; Demissie Y; Bedru A; Sahile M; Mengesha E; Dememew ZG; Tegegn B; Slyzkyi A; Amare M; Getahun M; Abdella S; Jerene D; Tiemersma E
    Microbiol Spectr; 2023 Aug; 11(4):e0117123. PubMed ID: 37358407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Costs and cost-effectiveness of Gene Xpert compared to smear microscopy for the diagnosis of pulmonary tuberculosis using real-world data from Arsi zone, Ethiopia.
    Kaso AW; Hailu A
    PLoS One; 2021; 16(10):e0259056. PubMed ID: 34695153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Simple One-step stool processing method for detection of Pulmonary tuberculosis: A study protocol to assess the robustness, stool storage conditions and sampling strategy for global implementation and scale-up.
    de Haas P; Yenew B; Diriba G; Amare M; Slyzkyi A; Demissie Y; Sherefdin B; Bedru A; Mengesha E; Dememew ZG; Kebede A; Getahun M; Tiemersma E; Jerene D
    PLoS One; 2022; 17(10):e0264103. PubMed ID: 36194578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Xpert MTB/RIF Ultra Results of Stool and Sputum in Children with Presumptive Tuberculosis in Southern Ethiopia.
    Babo Y; Seremolo B; Bogale M; Bedru A; Wabe Y; Churako H; Bilat A; Degaga T; de Haas P; Tiemersma E; Jerene D
    Trop Med Infect Dis; 2023 Jun; 8(7):. PubMed ID: 37505646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microscopic observation drug-susceptibility assay vs. Xpert
    Wikman-Jorgensen PE; Llenas-García J; Pérez-Porcuna TM; Hobbins M; Ehmer J; Mussa MA; Ascaso C
    Trop Med Int Health; 2017 Jun; 22(6):734-743. PubMed ID: 28380276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Standard diagnostics with and without urine-based lipoarabinomannan testing for tuberculosis disease in HIV-infected patients in a high-burden setting-A cost-effectiveness analysis.
    Fekadu G; Wang Y; You JHS
    PLoS One; 2023; 18(7):e0288605. PubMed ID: 37450476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delayed diagnosis and treatment of tuberculosis in HIV+ patients in Mozambique: A cost-effectiveness analysis of screening protocols based on four symptom screening, smear microscopy, urine LAM test and Xpert MTB/RIF.
    Orlando S; Triulzi I; Ciccacci F; Palla I; Palombi L; Marazzi MC; Giuliano M; Floridia M; Mancinelli S; Mutemba E; Turchetti G
    PLoS One; 2018; 13(7):e0200523. PubMed ID: 30024890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of GeneXpert Omni compared with GeneXpert MTB/Rif for point-of-care diagnosis of tuberculosis in a low-resource, high-burden setting in Eastern Uganda: a cost-effectiveness analysis based on decision analytical modelling.
    Ejalu DL; Irioko A; Kirabo R; Mukose AD; Ekirapa E; Kagaayi J; Namutundu J
    BMJ Open; 2022 Aug; 12(8):e059823. PubMed ID: 35998960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid, point-of-care diagnosis of tuberculosis with novel Truenat assay: Cost-effectiveness analysis for India's public sector.
    Lee DJ; Kumarasamy N; Resch SC; Sivaramakrishnan GN; Mayer KH; Tripathy S; Paltiel AD; Freedberg KA; Reddy KP
    PLoS One; 2019; 14(7):e0218890. PubMed ID: 31265470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Xpert MTB/RIF diagnosis of childhood tuberculosis from sputum and stool samples in a high TB-HIV-prevalent setting.
    Orikiriza P; Nansumba M; Nyehangane D; Bastard M; Mugisha IT; Nansera D; Mwanga-Amumpaire J; Boum Y; Kumbakumba E; Bonnet M
    Eur J Clin Microbiol Infect Dis; 2018 Aug; 37(8):1465-1473. PubMed ID: 29740714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness of TB diagnostic technologies in Ethiopia: a modelling study.
    Assebe LF; Erena AK; Fikadu L; Alemu B; Baruda YS; Jiao B
    Cost Eff Resour Alloc; 2024 May; 22(1):43. PubMed ID: 38773636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness of diagnostic algorithms including lateral-flow urine lipoarabinomannan for HIV-positive patients with symptoms of tuberculosis.
    Yakhelef N; Audibert M; Ferlazzo G; Sitienei J; Wanjala S; Varaine F; Bonnet M; Huerga H
    PLoS One; 2020; 15(1):e0227138. PubMed ID: 31999746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid diagnosis of tuberculosis with the Xpert MTB/RIF assay in high burden countries: a cost-effectiveness analysis.
    Vassall A; van Kampen S; Sohn H; Michael JS; John KR; den Boon S; Davis JL; Whitelaw A; Nicol MP; Gler MT; Khaliqov A; Zamudio C; Perkins MD; Boehme CC; Cobelens F
    PLoS Med; 2011 Nov; 8(11):e1001120. PubMed ID: 22087078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serological testing versus other strategies for diagnosis of active tuberculosis in India: a cost-effectiveness analysis.
    Dowdy DW; Steingart KR; Pai M
    PLoS Med; 2011 Aug; 8(8):e1001074. PubMed ID: 21857810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-Effectiveness of Currently Available Diagnostic Tools for Diagnosis of Pediatric Tuberculosis Under National Tuberculosis Elimination Program.
    Bhatia R; Chauhan A; Kaur K; Rana M; Singh M
    Indian J Community Med; 2023; 48(1):24-30. PubMed ID: 37082404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness of Low-complexity Screening Tests in Community-based Case-finding for Tuberculosis.
    Brümmer LE; Thompson RR; Malhotra A; Shrestha S; Kendall EA; Andrews JR; Phillips P; Nahid P; Cattamanchi A; Marx FM; Denkinger CM; Dowdy DW
    Clin Infect Dis; 2024 Jan; 78(1):154-163. PubMed ID: 37623745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost Analysis of Tuberculosis Diagnosis in Cambodia with and without Xpert
    Pallas SW; Courey M; Hy C; Killam WP; Warren D; Moore B
    Appl Health Econ Health Policy; 2018 Aug; 16(4):537-548. PubMed ID: 29862440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.